Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Erstveröffentlichung
2011
Wissenschaftlicher Artikel
Published in
The Lancet Infectious Diseases ; 11 (2011), 4. - S. 284-292. - ISSN 1473-3099. - eISSN 1474-4457
Link to publication
https://dx.doi.org/10.1016/S1473-3099(11)70024-XInstitutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: BONE-MARROW-TRANSPLANTATION | POLYMERASE-CHAIN-REACTION | GANCICLOVIR PROPHYLAXIS | PREEMPTIVE THERAPY | PP65 ANTIGENEMIA | INFECTION | VALACYCLOVIR | REACTIVATION | MULTICENTER | STRATEGIES[DDC subject group]: DDC 610 / Medicine & health